Sarclisa is a type of monoclonal antibody.
Sarclisa works by targeting a protein called CD38. This protein is found on some immune cells and cancer cells, including myeloma cells. Sarclisa may block CD38 and help the immune system kill cancer cells. This targeted action classifies it as a monoclonal antibody, a type of immunotherapy drug.
